Mutations that change the same amino acid can result in different clinical phenotypes. Through in silico modeling and keratin filament assessment of genetically engineered HaCaT cells, Natsuga et al., as reported in this issue, have demonstrated how changes in charge and structure of a replacement amino acid in keratin 14 can cause disease (KRT14pA413P, EB simplex) or no clinical effect (KRT14pA413T, polymorphism). © 2011 The Society for Investigative Dermatology.
CITATION STYLE
Murrell, D. F., Trisnowati, N., Miyakis, S., & Paller, A. S. (2011). The yin and the yang of keratin amino acid substitutions and epidermolysis bullosa simplex. Journal of Investigative Dermatology. Nature Publishing Group. https://doi.org/10.1038/jid.2011.206
Mendeley helps you to discover research relevant for your work.